0000000000113785

AUTHOR

Bulina Inita

showing 3 related works from this author

A10.8 Evaluation of Disease Activity in Adult Patients with Juvenile Idiopathic Arthritis

2013

Background Juvenile idiopathic arthritis (JIA) is a disease which maintains specific childish rheumatological features during whole life. There is still an open discussion which criteria of the disease activity should be used for the management of adult patients with JIA. Objectives To analyse the usefulness of known disease activity and functional indices used in adult rheumatological practise for the assessment of rheumatoid arthritis (RA) and spondyloarthritidies (SpA): disease acitivity score (DAS), disease acitivity score 28 (DAS28), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Spondylitis Functional Index (BASFI), Health Assessment Questionnaire – disability index…

musculoskeletal diseasesmedicine.medical_specialtyAnkylosing spondylitisbusiness.industryImmunologyArthritismedicine.diseaseConnective tissue diseaseGeneral Biochemistry Genetics and Molecular BiologyRheumatologyRheumatologyInternal medicineRheumatoid arthritismedicinePhysical therapyImmunology and Allergyskin and connective tissue diseasesbusinessBASFISpondylitisBASDAIAnnals of the Rheumatic Diseases
researchProduct

A10.18 Lack of Association of Serum Interleukin-17 and Interleukin-23 Levels with Disease Activity in Patients with Ankylosing Spondylitis in Latvia

2013

Background Ankylosing spondylitis (AS) is a clinically well-known chronic inflammatory disease of the axial skeleton and peripheral joints. The pathogenesis of this disease still remains a challenge. Determination of cytokine profile and its role involved in AS pathogenesis give an opportunity to extend the targeted therapeutic approach. Interleukin-17 (IL-17) and interleukin-23 (IL-23) are cytokines of interest in the investigation of the pathogenesis of spondyloarthritides although their importance in AS is not clearly defined. Objectives to investigate levels of IL-17 and IL-23 in a group of AS and in a demographically matched group of healthy subjects and its association with the diseas…

medicine.medical_specialtyAnkylosing spondylitismedicine.diagnostic_testbusiness.industryImmunologyInflammationDiseasemedicine.diseaseGastroenterologyGeneral Biochemistry Genetics and Molecular BiologyPathogenesisRheumatologyInternal medicineErythrocyte sedimentation rateImmunologyInterleukin 23Immunology and AllergyMedicineInterleukin 17medicine.symptombusinessBASDAIAnnals of the Rheumatic Diseases
researchProduct

A2.2 Uveitis is not associated with cardiovascular disease risk factors in patients with ankylosing spondylitis

2014

Background and Objectives Ankylosing spondylitis (AS) is a chronic, autoimmune, systemic, inflammatory disease. Recently, a link has been established between autoimmune inflammatory diseases, incl. AS, and the risk of developing cardiovascular disease (CVD). Uveitis is the most frequent extraarticular location of AS - it occurs in about 25 - 40% of patients. The impact of evidence of uveitis during the course of AS still remains a challenge. Does AS with uveitis differ from AS without uveitis? The objective of this study was to detect the link between uveitis during the course of AS and the CVD risk factors in patients with AS. Materials and Methods 77 AS patients classified using the modif…

medicine.medical_specialtyAnkylosing spondylitisWaistbusiness.industryCholesterolImmunologyDiseasemedicine.diseaseGastroenterologyGeneral Biochemistry Genetics and Molecular BiologySurgeryPathogenesischemistry.chemical_compoundHigh-density lipoproteinRheumatologychemistryInternal medicineImmunology and AllergyMedicinebusinessBody mass indexUveitisAnnals of the Rheumatic Diseases
researchProduct